SARS-COV-2 INFECTION
Clinical trials for SARS-COV-2 INFECTION explained in plain language.
Never miss a new study
Get alerted when new SARS-COV-2 INFECTION trials appear
Sign up with your email to follow new studies for SARS-COV-2 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Plasma from recovered patients tested against COVID-19 – trial ends early
Disease control TerminatedThis study tested whether giving plasma (the liquid part of blood) from people who recovered from COVID-19 could help hospitalized patients with moderate to severe COVID-19. The plasma contains antibodies that might fight the virus. The trial planned to enroll many patients but w…
Matched conditions: SARS-COV-2 INFECTION
Phase: PHASE3 • Sponsor: South African National Blood Service • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Nasal spray could be new weapon against COVID-19
Prevention TerminatedThis study tested whether a nitric oxide nasal spray could prevent COVID-19 in people at risk of exposure. About 1,400 adults used the spray or a placebo for 28 days. The trial was terminated early, so final results are not available.
Matched conditions: SARS-COV-2 INFECTION
Phase: PHASE3 • Sponsor: Sanotize Research and Development corp. • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC